Acasă › Cancer pulmonar cu celule non-pătrate › Wisconsin › Madison
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Madison, WI
16 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Madison (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
În curs de recrutareFaza 3
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0129), Madison
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Local Institution - 0135, Madison
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
În curs de recrutareFaza 1
- Wisconsin Institute for Medical Research, Madison
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- University Hospital and UW Health Clinics, Madison
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
În curs de recrutareFaza 1/2
- UW Health Carbone Cancer Center, Madison
HEARTS Trial for Thoracic Cancers
În curs de recrutareFaza 2
- University of Wisconsin - Madison, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
În curs de recrutareFaza 1/2
- The Board of Regents of the University of Wisconsin, Madison
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- University of Wisconsin - Carbone Cancer Center, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Wisconsin- Madison, Madison
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Wisconsin (Carbone Cancer Center), Madison
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
În curs de recrutareFaza 2
- Univeristy of Wisconsin, Madison
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Madison
- Cancer de prostată29 studii
- Cancer colorectal23 studii
- Cancer de sân22 studii
- Cancer metastatic21 studii
- Leucemie mieloasă acută16 studii
- Melanom15 studii
- Cancer (toate tipurile)14 studii
- Cancer ovarian13 studii
- Cancer gastric11 studii
- Cancer pancreatic10 studii
- Cancer pulmonar10 studii
- Mielom multiplu9 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.